Skip to content

The development and evaluation of an individualised information package for patients with rectal cancer

The development and evaluation of an individualised information package for patients with rectal cancer: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN42959693
Enrollment
94
Registered
2009-01-30
Start date
2008-12-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of the rectum Cancer Malignant neoplasm of rectum

Interventions

The intervention group will receive a series of leaflets from the newly designed information pack depending on their condition, treatment plan and choice of information. To assist people with literacy

Sponsors

Western Health and Social Care Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Both males and females, no age limits 2. Patients with a new diagnosis of rectal cancer

Exclusion criteria

Exclusion criteria: Patients at an advanced stage of illness who are under the care of the palliative care team or who are considered to have a prognosis of less than six months.

Design outcomes

Primary

MeasureTime frame
1. Satisfaction with information, assessed using Patient Satisfaction with Cancer Treatment Education (PS-Ca-TE) at T1, T2 and T3 2. Anxiety will be measured using the Hospital Anxiety and Depression Scale at T1, T2 and T3 3. Health behavioural style, assessed by the Monitor-Blunter style scale at T1 only 4. Preparation for Survivorship will be measured using Reintegration to Normal Living Index at T1, T2 and T3 Length of consultation with the Stoma Care Nurse Specialist and number of follow-up appointments with the Stoma Care Nurse Specialist will be recorded by the Stoma Care Nurse Specialist for the duration of the study for each participant. Timepoints for data collection: T1: At diagnosis T2: Just before discharge from hospital after surgery T3: Six months after T2

Secondary

MeasureTime frame
No secondary outcome measures

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026